Research map: 5-FU in combination with PARP inhibitor ABT-888 deregulates MGMT-dependent mismatch repair (MMR) pathway in MMR-proficient colorectal cancer stem cells by modulating MGMT/PARP1/MSH6 complex

Back to the article

Papers in this map

  1. The ClusPro web server for protein–protein docking · Dima Kozakov · 2017 · 3474 citations · Cited by this paper
  2. Advancements in the molecular understanding of major depressive disorder uncovering novel targets with therapeutic promise: focus on recurrence of illness · 2025 · Related
  3. CB-Dock2: improved protein–ligand blind docking by integrating cavity detection, docking and homologous template fitting · Yang Liu · 2022 · 2075 citations · Cited by this paper
  4. Modulating tonic NMDA receptor currents: mechanistic insights into ketamine, esketamine, and dextromethorphan for major depressive disorder and implications for the discovery and development of investigational agents · 2026 · Related
  5. Survival of Patients With Advanced Colorectal Cancer Improves With the Availability of Fluorouracil-Leucovorin, Irinotecan, and Oxaliplatin in the Course of Treatment · Axel Grothey · 2004 · 1083 citations · Cited by this paper
  6. Molecular targets in gastric cancer for nanomedicine therapeutics: mechanistic insights and translational progress · 2026 · Related
  7. Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment · Lan Thi Hanh Phi · 2018 · 1028 citations · Cited by this paper
  8. AQP7 suppresses cell stemness and metastasis by targeting Wnt signaling in basal-like breast cancer · 2026 · Related
  9. How do lncRNAs regulate transcription? · Yicheng Long · 2017 · 724 citations · Cited by this paper
  10. CDK7 as a New therapeutic target in pancreatic and lung cancer: current evidence and future perspectives · 2025 · Related
  11. Surgery for colorectal cancer in elderly patients: a systematic review · PD Simmonds · 2000 · 603 citations · Cited by this paper
  12. Advances in CGRP therapeutic targets for migraine: where do we stand 5 years later? · 2026 · Related
  13. 5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition · Chinmayee Sethy · 2021 · 552 citations · Cited by this paper
  14. Transient receptor potential (TRP) channels: an emerging therapeutic target for the treatment of cardiac hypertrophy · 2026 · Related
  15. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases · Daria Zorzi · 2007 · 539 citations · Cited by this paper
  16. Lipopolysaccharide-targeting treatments for multidrug-resistant Pseudomonas aeruginosa · 2026 · Related
  17. 5‐Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes · Sabrina Blondy · 2020 · 510 citations · Cited by this paper
  18. Unveiling the role of mineralocorticoid receptor antagonists in epilepsy: the intersection of seizures, stress, and neuroinflammation · 2025 · Related
  19. Human MutSalpha recognizes damaged DNA base pairs containing O6-methylguanine, O4-methylthymine, or the cisplatin-d(GpG) adduct. · D R Duckett · 1996 · 425 citations · Cited by this paper
  20. An overview of outer membrane protein A (OmpA) as a therapeutic target for Acinetobacter baumannii infection · 2026 · Related
  21. Colorectal Cancer: Epidemiology, Risk Factors, and Prevention · Gholamreza Roshandel · 2024 · 423 citations · Cited by this paper
  22. Structure of the Human MutSα DNA Lesion Recognition Complex · Joshua J. Warren · 2007 · 376 citations · Cited by this paper
  23. Determinants of metastatic competency in colorectal cancer · Daniele V. F. Tauriello · 2017 · 284 citations · Cited by this paper
  24. O6-Methylguanine-DNA Methyltransferase (MGMT): Challenges and New Opportunities in Glioma Chemotherapy · Wei Yu · 2020 · 272 citations · Cited by this paper
  25. Current and emerging therapeutic approaches for colorectal cancer: A comprehensive review · Anil Kumar · 2023 · 266 citations · Cited by this paper
  26. Participation of DNA repair in the response to 5-fluorouracil · Michael D. Wyatt · 2008 · 250 citations · Cited by this paper
  27. Targeting DNA Repair Pathways for Cancer Treatment: what’s new? · Mark R. Kelley · 2014 · 206 citations · Cited by this paper
  28. The Developing Story of Predictive Biomarkers in Colorectal Cancer · Stergios Boussios · 2019 · 169 citations · Cited by this paper
  29. PARP-mediated PARylation of MGMT is critical to promote repair of temozolomide-induced O6-methylguanine DNA damage in glioblastoma · Shaofang Wu · 2021 · 155 citations · Cited by this paper
  30. Targeting O 6-methylguanine-DNA methyltransferase with specific inhibitors as a strategy in cancer therapy · Bernd Kaina · 2010 · 149 citations · Cited by this paper
  31. The poly(ADP-Ribose) polymerase inhibitor ABT-888 reduces radiation-induced nuclear EGFR and augments head and neck tumor response to radiotherapy · Somaira Nowsheen · 2011 · 94 citations · Cited by this paper
  32. Evaluation of poly (ADP-ribose) polymerase inhibitor ABT-888 combined with radiotherapy and temozolomide in glioblastoma · Lara Barazzuol · 2013 · 93 citations · Cited by this paper
  33. A role for DNA mismatch repair in sensing and responding to fluoropyrimidine damage · Mark Meyers · 2003 · 71 citations · Cited by this paper
  34. Effect of vildagliptin and pravastatin combination on cholesterol efflux in adipocytes · Ahmed M. Mostafa · 2016 · 71 citations · Cited by this paper
  35. The PARP inhibitor ABT-888 synergizes irinotecan treatment of colon cancer cell lines · David Lyman Davidson · 2012 · 68 citations · Cited by this paper
  36. Depletion of O6-methylguanine-DNA methyltransferase by O6-benzylguanine enhances 5-FU cytotoxicity in colon and oral cancer cell lines · Jun Murakami · 2007 · 64 citations · Cited by this paper
  37. LncRNA NNT-AS1/hsa-miR-485–5p/HSP90 axis in-silico and clinical prospect correlated-to histologic grades-based CRC stratification: A step toward ncRNA Precision · Nada M. El-Sheikh · 2023 · 62 citations · Cited by this paper
  38. O6-Methylguanine-Methyltransferase (MGMT) Promoter Methylation Status in Glioma Stem-Like Cells is Correlated to Temozolomide Sensitivity Under Differentiation-Promoting Conditions · Claire Villalva · 2012 · 58 citations · Cited by this paper
  39. Camptothecin structure simplification elaborated new imidazo[2,1-b]quinazoline derivative as a human topoisomerase I inhibitor with efficacy against bone cancer cells and colon adenocarcinoma · Ahmed I. A. Khodair · 2023 · 49 citations · Cited by this paper

Source: OpenAlex (CC0)